Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

2 out of 5 AFib patients develop heart failure later in life
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
Cardiologist-approved VR for interventional procedures headed to ACC.24
San Francisco-based Osso VR and the American College of Cardiology have collaborated on advanced LAAO simulations. The two groups first started working together back in 2022.
Biosense Webster takes key step toward FDA approval for Varipulse PFA system
The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.
Going green in the cath lab makes economic sense
New research explored the potential savings of turning off angiography systems at night and on weekends.

QDOT MICRO Biosense Webster Johnson and Johnson. The QDOT MICRO catheter is contact force-sensing device designed for temperature-controlled RF ablation. It received CE mark approval in 2020 and U.S. Food and Drug Administration approval in 2022. When in the QMODE+ setting, the device delivers high-power ablation for up to four seconds per burst, a feature designed to improve the ablation’s likelihood of success.

Next-gen RF catheter from Biosense Webster improves QOL in patients with paroxysmal AFib

After 12 months, researchers found that the device was associated with control of AFib in 99% of patients and relief from AFib symptoms in 93.1% of patients.

November 2, 2023

Samir Kapadia, MD, Cleveland Clinic, explains the WATCH TAVR study results that combined LAAO with transcatheter aortic valve replacement at TCT 2023. #TCT2023 #TAVR #Watchman #LAAO

TAVR and LAAO at the same time? Samir Kapadia breaks down the WATCH-TAVR trial

Could this late-breaking clinical trial from TCT 2023 be a sign of things to come in the years ahead? Samir Kapadia, MD, explored the topic in a new interview.

November 2, 2023

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

October 25, 2023

Medtronic extravascular ICD Aurora EV-ICD MRI SureScan

FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

October 24, 2023

Technology that creates interactive holograms of the heart cleared by FDA

SentiAR's CommandEP interface facilitates 3D models of the heart, made possible through augmented reality.

October 16, 2023

Video of Christina Albert, MD, MPH chair, Department of Cardiology, Cedars-Sinai, explaining the changing approaches to sudden cardiac arrest. #SCA #SCD #ESC #ESC23 #ESC2023

Changing approaches to the treatment of sudden cardiac arrest

Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christina Albert, MD, about this and much more at ESC 2023.

October 9, 2023

Artificial intelligence (AI) is being developed to help make cardiovascular clinical trials more efficient, lead to faster advances in patient care, and bring possible new treatments to heart patients more quickly. The major cardiac research center of Icahn School of Medicine at Mount Sinai announced today that it signed a memorandum of understanding with the Chiba Institute of Technology (CIT) to collaborate on using AI to enhance cardiovascular disease research.

Mount Sinai partners with the Chiba Institute of Technology on AI to transform cardiovascular research

Agreement aims to use AI to help make cardiology clinical trials more efficient and lead to faster advances in patient care.

October 5, 2023

Cardiologist compensation much higher at hospitals and health systems than private practices—and the gap is widening

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States.

October 3, 2023

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Electrophysiology

2 out of 5 AFib patients develop heart failure later in life

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

Cardiologist-approved VR for interventional procedures headed to ACC.24

Biosense Webster takes key step toward FDA approval for Varipulse PFA system

Going green in the cath lab makes economic sense

Around the web